BMY vs HOMB · P/E 17, rev $24.46B vs P/E 11, rev $647.9M
Bristol-Myers Squibb Company (BMY) versus Home BancShares Inc (HOMB) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Christopher S. Boerner Ph.D..
Home BancShares Inc (HOMB) is a banks - regional company listed on NYSE.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported HOMB revenue for 2026-06-30 was $647.9M. HOMB currently screens at market cap $5.53B and trailing P/E 11.3.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. HOMB currently screens at market cap $5.53B and trailing P/E 11.3.
Not investment advice. Open the BMY and HOMB stock pages for the full models.
Not investment advice.